Best Pope County Grants for Nonprofits in Minnesota

The Gerald Kahan Scholar's Prize, awarded by the American Society for Theatre Research, honors the best essay published in English in a refereed scholarly journal or edited collection within the field of theater research. Eligible authors must be untenured and within seven years of their doctorate or enrolled in a doctoral program. The prize includes a $500 honorarium and complimentary registration for the ASTR annual meeting, acknowledging the editor's contribution to scholarship.

The ASTR Translation Prize recognizes the vital contributions of translators in theater and performance studies. It honors an exceptional English translation of works such as plays, performance texts, scholarly books, and articles published in the last calendar year. The award includes a $500 honorarium and free registration to the annual ASTR conference, promoting the importance of translations in enhancing the global theater landscape.

The ASTR Jessica Berson Dance Research Assistance Fund Grant aims to support contingent faculty engaged in dance-based scholarship within theatre. This initiative acknowledges the critical role of non-tenure track faculty and provides them with a $1000 honorarium, conference registration, and a one-year ASTR membership. The grant encourages research and attendance at the annual ASTR conference, ensuring broader access to resources and professional opportunities for those who often lack institutional support.

The ASTR Teacher-Researchers Grant supports faculty with heavy teaching loads and limited research resources in theatre studies. This grant fosters scholarly exchange by providing an honorarium of up to $1000, complimentary conference registration, and a one-year ASTR membership. Applications are evaluated based on project feasibility and significance, with additional consideration for those facing institutional research support challenges. This initiative aims to enhance diversity and facilitate meaningful contributions to the field.

The ASTR Brooks McNamara Publishing Subvention supports costs related to reproducing illustrations for publications, including securing rights and acquiring images. It is available to independent or affiliated scholars with terminal degrees who are ASTR members. The award offers up to $600, with preference given to junior scholars. Projects will be evaluated based on their merit within theatre, dance, and performance studies, as well as the scholar's research endeavors.

The ASTR Theater and Performance Art Studies Research Fellowships provide funding for scholars conducting significant research in theatre and performance studies. With awards up to $3000, these fellowships support academic projects, allowing recipients to cover various research expenses. Eligible applicants include anyone holding a terminal degree and a member of ASTR, with the selection based on project merit. However, applicants cannot seek a Targeted Research Area Grant for the same project in the same year.

The ASTR Targeted Research Area Grant supports projects by scholars focusing on under-represented areas in theatre, dance, and performance studies. This includes research on Asian, African, Latin American, and Middle Eastern disciplines, as well as pre-1900 studies and essential translations. The grant, offering up to $3000, encourages recipients to publish their findings and collaborate with Theatre Survey editors. Eligibility extends to scholars with terminal degrees and graduate students, provided they are ASTR members.

The ASTR Po-Hsien Chu International Scholar Award Fund aims to support international scholars facing unique challenges in the U.S. due to their visa status. This initiative offers annual research awards to up to two scholars, with a focus on at least one Asian recipient. The $1000 honorarium promotes access to funding for groundbreaking research in theatre and performance studies and encourages recipients to engage with the ASTR community through conferences and mentoring.

The Sidney R. Baer, Jr. Foundation offers Criminal Justice Grants aimed at improving the lives of individuals with serious mental illnesses, particularly schizophrenia and bipolar disorder. With an emphasis on effective programs and support services, the foundation seeks to address the challenges faced by mentally ill individuals in the criminal justice system. The foundation prioritizes organizations that demonstrate a commitment to making a meaningful impact and improving the quality of life for those affected by these conditions.

The Sidney R. Baer, Jr. Foundation offers Reintegration Grants aimed at supporting individuals with schizophrenia and bipolar disorder. By focusing on abilities rather than symptoms, the foundation promotes recovery through various programs. Their funding helps organizations that maintain a commitment to mental health, ensuring that recipients receive necessary support, such as scholarships and facility management, to enhance their quality of life. The foundation believes in empowering individuals to actively participate in their recovery journey.

The Sidney R. Baer, Jr. Foundation offers Social Support Grants aimed at improving the lives of individuals living with schizophrenia and bipolar disorder. These grants focus on reducing stigma through education and advocacy, fostering a compassionate environment. The foundation prioritizes organizations that provide tangible support and resources, ensuring a meaningful impact on mental health. By addressing the challenges faced by those with mental illness, the foundation strives to create a more inclusive society that recognizes and supports their needs.

The Sidney R. Baer, Jr. Foundation offers Clinical Research Grants to support advancements in the treatment and understanding of schizophrenia and bipolar disorder. Focused on organizations with IRS tax-exempt status, these grants aim to enhance mental health services and research. By funding initiatives in cognitive and behavioral sciences, the foundation seeks to improve the lives of those affected by serious mental illness, ensuring they receive the support and resources necessary for a better quality of life.

The Melanoma Career Development Award (CDA) is offered by the Melanoma Research Foundation to support researchers dedicated to melanoma and its prevention. This award is designed for postdoctoral fellows with under five years of experience, research associates, scientists, staff scientists, assistant professors, and those focusing on melanoma prevention. The initiative promotes innovative research to advance understanding and treatment of melanoma, ultimately aiming to reduce its impact.

The Cooperative Education Fund, managed by the Cooperative Development Foundation, offers grants, scholarships, and sponsorships to support cooperative education initiatives. Annually, it allocates between $100,000 and $140,000, providing 10-15 grants ranging from $1,000 to $10,000. Eligible applicants include cooperatives and related organizations within the U.S. The Fund prioritizes research, educational material development, and sponsorship for educational events, ensuring resources remain accessible and non-proprietary.

The Cooperative Development Fund Grant supports cooperative development, research, and technical assistance for cooperatives focused on seniors, international development, and affordable housing. Grants, typically ranging from $20,000 to $30,000, are awarded once a year, with a two-stage application process: a concept paper followed by a full proposal for selected applicants. Up to two grants are awarded annually, with decisions announced shortly after the Advisory Board meeting in January.

The Spark Good: Strengthening Community Local Grants program by the Wal-Mart Foundation empowers local organizations through grants ranging from $250 to $5000. This initiative aims to enhance community welfare by supporting diverse projects, including animal shelters and educational programs. Eligible organizations must have a verified Spark Good account, ensuring funds are allocated effectively to meet local needs and foster community development. Together, we can create lasting impacts through small yet significant actions.

The Therapeutic Giving program by Johnson & Johnson Innovative Medicine focuses on supporting nonprofit organizations that enhance patient access to treatment in cardiovascular and metabolic health. Applications are encouraged for initiatives that promote education, empower patients, and address healthcare disparities. Eligible organizations must be IRS 501(c)(3) certified, with a preference for programs demonstrating measurable outcomes. The funding period for local organizations extends from January to October 15th, while national organizations can apply in September.

The Therapeutic Giving program by Johnson & Johnson Innovative Medicine focuses on enhancing patient access to treatment in cardiovascular and metabolism areas. Nonprofit organizations classified as 501(c)(3) are eligible to apply for funding. The program emphasizes innovative initiatives that address healthcare disparities and improve patient outcomes through education, advocacy, and support services. Applications are evaluated based on design, capacity, and potential impact, with a preference for programs over event-based funding.

The Therapeutic Giving program by Johnson & Johnson focuses on funding initiatives that enhance patient access to treatment and advance health equity, particularly in immunology. Eligible nonprofit organizations can apply for support aimed at improving health outcomes through innovative programs. The initiative prioritizes measurable impacts over fundraising activities, emphasizing the importance of addressing healthcare disparities and promoting disease awareness efforts for diseases like rheumatoid arthritis and psoriasis.

The Therapeutic Giving: Oncology program by Johnson & Johnson focuses on funding initiatives that enhance patient access to treatments and services, promote health equity, and strengthen healthcare workforces. It supports programs that raise disease awareness, empower patients, and improve health systems with measurable outcomes. Eligible applicants include nonprofit organizations with 501(c)(3) status, emphasizing innovative programs addressing healthcare disparities and unmet needs.

The Therapeutic Giving program from Johnson & Johnson Innovative Medicine aims to support local and regional organizations focused on improving patient access to treatment and advancing health equity. Eligible applicants include 501(c)(3) nonprofit organizations, with funding preferences for programs that address significant healthcare disparities, mental health initiatives, and innovative solutions with measurable outcomes. The application period for local organizations runs from March 1 to May 31, while national organizations can apply in September.

The Therapeutic Giving initiative by Johnson & Johnson focuses on funding programs in neuroscience aimed at enhancing patient access to treatments and promoting health equity. Nonprofit organizations classified as 501(c)(3) can apply for support from March 1 to May 31. The initiative emphasizes innovative, measurable programs in areas like Alzheimer’s disease and mental health, prioritizing those that address healthcare disparities and improve quality of life for affected individuals.

The NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award supports investigator-initiated clinical trials of natural products, including botanicals and dietary supplements. This funding opportunity aims to validate the pharmacokinetics and bioavailability of these products over three years in a phased approach. Successful trials will provide crucial data for further development and clinical application, emphasizing the importance of scientifically driven research in natural product efficacy.

The NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) promotes innovative clinical trials on natural products, such as botanicals and dietary supplements. This funding opportunity supports studies that demonstrate significant scientific rationale and preliminary evidence for efficacy. Applications can explore various delivery methods and combinations with existing treatments to enhance outcomes. Funding is available for up to three years, aimed at bridging basic science discoveries into practical clinical applications.

The NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) invites applications for mid-phase clinical trials involving natural products like botanicals and dietary supplements. The goal is to advance clinical testing through robust preliminary data, ensuring these products demonstrate measurable impacts on target engagement. Submission deadlines span from March 2024 to October 2026. Applications must focus on optimizing doses and identifying patient responders to inform future efficacy trials, aligning with NCCIH's research priorities.

The Quality Improvement Awards, sponsored by the Anesthesia Patient Safety Foundation (APSF), aim to enhance patient safety during anesthesia care. This initiative invites current trainees and recent graduates to showcase their quality improvement projects. Winners will receive sponsorship to attend the Stoelting Conference in Massachusetts, where they will present their work. The APSF is committed to promoting a culture of safety and learning in anesthesia, ensuring that no one is harmed by anesthesia care.

The External Collaborative Research (ECR) program by Boehringer Ingelheim invites academic and community scientists to propose collaborative studies aimed at protocol development and result publication. This program offers potential drug and financial support, excluding direct salary for the Principal Investigator. Budgets must represent fair market value and will be negotiated further. Research interests span therapeutic areas including Cardio-Renal-Metabolic, Mental Health, Dermatology, and Oncology, encouraging innovative solutions to unmet medical needs.